Harish Potu

Harish Potu is a Senior Principal Scientist at NeoSome Life Sciences, specializing in preclinical drug development in oncology since February 2023. Prior to this role, Harish served as a Principal Scientist at Cytovia Therapeutics from December 2021 to February 2023, where responsibilities included establishing the in vivo pharmacology department and leading preclinical proof of concept studies for CAR-NK therapies. Harish also held the position of Senior Scientist at Biocytogen and worked at the University of Michigan Medical School for nearly a decade as a Research Investigator and Postdoctoral Research Fellow, focusing on early drug discovery, target validation, and mechanism of action research. Harish earned a Ph.D. in Cancer Biology from Università degli Studi di Udine, contributing to significant research publications in the field.